Our results suggest that BRCA1/2 function in the HR-dependent bypass of lesions that block DNA replication and that this repair pathway is used to reduce APOBEC-induced mutations in tumor cells, helping to define some of the genetic components of this pathway. This evidence concerns the gene BRCA1 and neoplasm.